Aarvik Therapeutics has secured a successful Series Seed 2 financing round. This funding will help advance the company's proprietary MUTTA™ platform and reach targeted research milestones.
Round Type
Seed
HaywardBiotechnologyHealthcareHealth CareTherapeuticsresearchDescription
Aarvik Therapeutics has successfully closed a Series Seed 2 financing round with a diverse set of investors. The funding validates Aarvik's substantial progress on its MUTTA™ platform. It will enable the company to further advance its pipeline of ADC assets. The new round follows its previous Series Seed financing.
Quick answer
Aarvik Therapeutics raised an undisclosed amount in a Seed round, dated September 29, 2025. Aarvik Therapeutics is based in Hayward, California, United States.
- How much did Aarvik Therapeutics raise?
- Aarvik Therapeutics raised an undisclosed amount in a Seed round on September 29, 2025.
- What does Aarvik Therapeutics do?
- Aarvik Therapeutics is pursuing exciting, novel molecules with an improved therapeutic index for several oncology targets by combining a novel modular antibody platform with multiple target mechanisms.
- Where is Aarvik Therapeutics based and how big is it?
- Aarvik Therapeutics is based in Hayward, California, United States. Fundz records about 10 employees.
- Who are the decision-makers at Aarvik Therapeutics?
- Fundz holds 1 contact at Aarvik Therapeutics, including the Director. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Healthcare and Therapeutics around the same time
Companies in the same sectors as Aarvik Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Damora Therapeutics, Inc. raised $285M on November 12, 2025.
- Brainstorm Cell Therapeutics raised $155K (Convertible Note) on November 6, 2025.
- Pelthos Therapeutics raised $18M on November 6, 2025.
- Phio Pharmaceuticals raised $1.4M on November 4, 2025.
- AAVantgarde Bio raised $141M (Series B) on November 3, 2025.
- Faeth Therapeutics raised $25M (Funding Round) on October 20, 2025.
Who to call at Aarvik Therapeutics, and when
A new round usually means Aarvik Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Aarvik Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Aarvik Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Aarvik Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Aarvik Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Aarvik Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.